William Nowatzke, Ph.D., DABCC
Senior Director Commercial Laboratory Operations
Dr. Bill Nowatzke has nearly twenty years of academic, industry, and CRO experience supporting clinical diagnostics, pharmaceutical development programs, and the measurement of biomarkers in various biological matrices. After receiving a Ph.D. in chemistry at Indiana University, Bill completed a postdoctoral fellowship in clinical chemistry at Washington University School of Medicine. He transitioned to the Department of Medicine providing leadership in a CLIA laboratory developing and validating laboratory-developed tests for esoteric biomarker testing in support of late phase safety and efficacy clinical trials.
Bill’s more recent focus has been providing bioanalytical support for biological therapeutics and assessing the efficacy of drug candidates. These activities include developing and validating bioanalytical methods and managing the analysis of samples in support of pharmacokinetic, anti-drug antibody, and biomarker utilizing immunoassay platforms.
Bill has remained active in professional organizations and continues to publish and speak on challenging issues related to the advancement of bioanalytical techniques.